Co-creation – the joint production of innovation between combinations of industry, research, government and civil society – was widely used to respond to COVID-19 challenges. This paper analyses 30 international co-creation initiatives that were implemented to address COVID-19 challenges.

Co-creation – the joint production of innovation between combinations of industry, research, government and civil society – was widely used to respond to the challenges raised by the COVID-19 pandemic. This paper describes 30 COVID-19 co-creation initiatives from 21 countries and three international cases.

This document presents the key learnings from discussions about engaging lived experience experts and representatives to inform the development of Lived Experience Outcome Indicators, in the context of publicly-funded mental health and alcohol and other drugs (AOD) services in Western Australia.

This paper argues that each co-design activity requires its own approach to suit the situation. This approach must be adjusted to work with the specific goals, the clients, the problem, the context, the culture, previous experience and resources.

The terms ‘co-creation’, ‘co-design’ and ‘co-production’ have been used interchangeably to describe the development of initiatives involving multiple stakeholders. While commonalities exist across these concepts, they have essential distinctions for public health, particularly related to the role of stakeholders and the extent and timing of their engagement. This paper summarises these similarities and differences.